Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review
10.1155/2018/1015239
Saved in:
Main Authors: | You, R., Qian, X., Tang, W., Xie, T., Zeng, F., Chen, J., Zhang, Y., Liu, J. |
---|---|
Other Authors: | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
Format: | Review |
Published: |
Hindawi Limited
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/213300 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease
by: Kritvikrom Durongpisitkul, et al.
Published: (2018) -
Pulmonary arterial hypertension in pregnancy-a systematic review of outcomes in the modern era.
by: Low, Ting-Ting, et al.
Published: (2021) -
Does pulmonary artery pulsatility index predict mortality in pulmonary arterial hypertension?
by: Lim, Yinghao, et al.
Published: (2021) -
Clinical indicators for pulmonary arterial hypertension in thalassemia
by: Chueamuangphan N., et al.
Published: (2014) -
Pulmonary Arterial Hypertension and Interstitial Lung Diseases
by: Robert P. Baughman, Roberto G. Carbone, Giovanni Bottino
Published: (2017)